Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15266065 | 0.92 | TSHR (0.40) | TSHRALDH1A1DNM1 | |
| SCHEMBL15309367 | 0.87 | — | — | |
| SCHEMBL798042 | 0.83 | TSHR (0.39) | TSHRALDH1A1SMN1; SMN2DNM1 | |
| SCHEMBL2525472 | 0.83 | TSHR (0.39) | TSHRALDH1A1SMN1; SMN2DNM1 | |
| SCHEMBL16177286 | 0.81 | TSHR (0.37) | TSHRALDH1A1SMN1; SMN2DNM1 | |
| SCHEMBL3481885 | 0.79 | DNM1 (0.39) | TSHRALDH1A1SMN1; SMN2DNM1 | |
| SCHEMBL6838265 | 0.79 | TSHR (0.36) | TSHRALDH1A1SMN1; SMN2DNM1 | |
| SCHEMBL15090866 | 0.79 | ALDH1A1 (0.33) | TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL1158829 | 0.79 | TSHR (0.36) | TSHRALDH1A1SMN1; SMN2DNM1 | |
| SCHEMBL15210243 | 0.79 | TSHR (0.36) | TSHRALDH1A1SMN1; SMN2DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7790350-B2 | Method and materials for patterning a neutral surface | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-09-07 | — | — | US | claimed |
| US-20090035668-A1 | Method and materials for patterning a neutral surface | GLOBALFOUNDRIES U.S. INC. | 2009-02-05 | — | — | US | claimed |
| US-9790223-B2 | Process for preparation of sodium (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate | WOCKHARDT LIMITED (IN) | 2017-10-17 | — | — | US | disclosed |
| EP-3116875-A1 | A PROCESS FOR PREPARATION OF SODIUM (2S, 5R)-6-(BENZYLOXY)-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXYLATE | Wockhardt Limited (IN) | 2017-01-18 | — | — | EP | disclosed |
| US-20170008892-A1 | PROCESS FOR PREPARATION OF SODIUM (2S, 5R)-6-(BENZYLOXY)-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXYLATE | WOCKHARDT LIMITED (IN) | 2017-01-12 | — | — | US | disclosed |
| EP-3057944-A1 | A NOVEL PROCESS FOR THE PREPARATION OF CHIRAL CYCLOPENTANONE INTERMEDIATES | Pharmathen S.A. (GR) | 2016-08-24 | — | — | EP | disclosed |
| WO-2015136473-A1 | A PROCESS FOR PREPARATION OF SODIUM (2S, 5R)-6-(BENZYLOXY)-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXYLATE | WOCKHARDT LIMITED (IN) | 2015-09-17 | — | — | WO | disclosed |
| WO-2015051903-A1 | A NOVEL PROCESS FOR THE PREPARATION OF CHIRAL CYCLOPENTANONE INTERMEDIATES | PHARMATHEN S.A. (GR) | 2015-04-16 | — | — | WO | disclosed |
| US-7790350-B2 | Method and materials for patterning a neutral surface | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2010-09-07 | — | — | US | disclosed |
| US-20090035668-A1 | Method and materials for patterning a neutral surface | GLOBALFOUNDRIES U.S. INC. | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170008892-A1 | PROCESS FOR PREPARATION OF SODIUM (2S, 5R)-6-(BENZYLOXY)-7-OXO-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXYLATE | SCN1B, SCN7A, ANO2 | TSHR 2201/4885ALDH1A1 255/4885SMN1; SMN2 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.